| [1] LaBrecque D R, Steele G, Fogerty S, et al. Purification and physical-chemical characterization of hepatic stimulator substance [J]. Hepatology, 1987, 7: 100-106.[2] Sebolt-Leopold J S, Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer[J]. Nat Rev Cancer, 2004, 4(12):937-947.[3] LaBrecque D R, Pesch L A. Preparation and partial characterization of hepatic regenerative stimulator substance(ss) from rat liver [J]. J Physiol, 1975, 248(2): 273-284.[4] Starzl T E, Jones A F, Terblanche J, et al. Growth-stimulating factor in regenerating canine liver[J]. Lancet,1979,1(8108): 127-130.[5] Francavilla A, Ove P, Polimeno L, et al. Extraction and partial purification of a hepatic stimulatory substance in rats, mice and dogs [J]. Cancer Res, 1987, 47(21): 5600-5605.[6] Fleig W E, Hoss G. Partial purification of rat hepatic stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes [J]. Hepatology, 1989, 9(2): 240-248.[7] LaBrecque D R. In vitro stimulation of cell growth by hepatic stimulator substance [J]. Am J Physiol, 1982, 242(3): G289-G295.[8] Farrell S R, Thorpe C. Augmenter of liver regeneration: a flavin-dependent sulfhydryl oxidase with cytochrome c reductase activity [J]. Biochemistry, 2005, 44(5): 1532-1541.[9] Wu Y, Chen L, Yu H, et al. Transfection of hepatic stimulator substance gene desensitizes hepatoma cells to H2O2-induced cell apoptosis via preservation of mitochondria[J]. Arch Biochem Biophys, 2007, 464(1): 48-56.[10] Dong L Y, Wang X N, Song Z G, et al. Identification of human hepatic stimulator substance gene promoter and demonstration of dual regulation of AP1/AP4 cis-acting element in different cell lines [J]. Int J Biochem Cell Biol, 2007, 39(1): 181-196.[11] Guo D, Dong L Y, Wu Y, et al. Downregulation of hepatic nuclear factor 4α on expression of human hepatic stimulator substance via its action on the proximal promoter in HepG2 cells [J]. Biochem J, 2008, 415(1): 111-121.[12] Dong L Y, Sun G Y, Jiang L, et al. Epidermal growth factor down-regulates the expression of uman hepatic timulator substance via CCAAT/enhancer-binding proteinβin HepG2 cells [J]. Biochem J, 2010, 431(2): 277-287.[13] Wang W L, Lee Y C, Yang W M, et al. Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription[J]. Nucleic Acids Res, 2008, 36(19): 6066-6079.[14] Hendricks-Taylor L R, Darlington G J. Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. [J]. Nucleic Acids Res, 1995, 23(22): 4726-4733.[15] Schuster M B, Porse B T. C/EBPalpha: a tumour suppressor in multiple tissues [J]. Biochim Biophys Acta, 2006, 1766(1): 88-103.[16] Juskeviciute E, Vadigepalli R, Hoek J B. Temporal and functional profile of the transcriptional regulatory network in the early regenerative response to partial hepatectomy in the rat [J]. BMC Genomics, 2008, 9: 527. |
